Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Jurnal Farmasi dan Sains Indonesia (JFSI)
Yuliasari, Niken
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Medicine & Pharmacology Neuroscience

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
MONITORING SIDE EFFECTS OF ANTITUBERCULOSIS DRUGS (OATS) IN PATIENTS WITH TUBERCULOSIS AT TUGUREJO REGIONAL GENERAL HOSPITAL SEMARANG Yuliasari, Niken; Gloria, Fransisca; Dahliyanti, Novita Dwi; Ovikariani, Ovikariani; Sa’adah, Anifatus; Suwarni, Sri
Jurnal Farmasi & Sains Indonesia Vol 8 No 1 (2025)
Publisher : LPPM Sekolah Tinggi Ilmu Farmasi Nusaputera

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52216/jfsi.vol8no1p21-25

Abstract

Monitoring of side effects of antituberculosis drugs (OAT) in tuberculosis (TB) patients during the intensive treatment phase. Tuberculosis, caused by Mycobacterium tuberculosis, requires the use of OAT which can cause a variety of side effects. Research shows that common side effects experienced by TB patients include joint pain, nausea, lack of appetite, and dizziness. The high incidence of these side effects has the potential to affect patient compliance in undergoing treatment, which has an impact on the success of TB therapy. The research method used is descriptive observation with a cross-sectional approach. Data was taken from patients undergoing treatment at various hospitals and health centers. The results showed that most patients experienced mild side effects, with frequency varying depending on the week of treatment. In the first week, almost all patients reported side effects, while the frequency tended to decrease over time. Regular monitoring of OAT side effects is essential to improve patient compliance and prevent treatment discontinuation. Health workers are expected to conduct periodic evaluations and provide support to patients to stay motivated. With effective monitoring, the risk of serious side effects can be minimized, and treatment outcomes for TB patients can be improved.
Co-Authors Dahliyanti, Novita Dwi Gloria, Fransisca Ovikariani, Ovikariani Sa’adah, Anifatus Sri Suwarni